Neurology and Neurosurgery - Global Neurology Academy

289-304 of 546

MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiers
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Amy Kuceyeski, PhD
- Amy Kuceyeski, PhD
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiers
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Christopher Lock, MD
- Christopher Lock, MD
Multiple Sclerosis Explained: Understanding Its Epidemiology
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiers
Multiple Sclerosis Explained: Understanding Its Epidemiology
Jonathan E. Howard, MD
- Jonathan E. Howard, MD
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiers
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Maxwell H. Levy, MD
- Maxwell H. Levy, MD
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple Sclerosis
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Marisa McGinley, DO
- Marisa McGinley, DO
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiers
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
David Kimhy, PhD
- David Kimhy, PhD
Genetics and Schizophrenia: Key Ethical Considerations
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiers
Genetics and Schizophrenia: Key Ethical Considerations
Aaron Besterman, MD
- Aaron Besterman, MD
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
NeuroFrontiers
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
On the Frontlines of Multiple Sclerosis
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Glenn Wylie, DPhil
- Glenn Wylie, DPhil
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiers
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Natalie Bareis, PhD, LMSW
- Natalie Bareis, PhD, LMSW
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiers
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Natalie Bareis, PhD, LMSW
- Natalie Bareis, PhD, LMSW
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
NeuroFrontiers
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiers
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
NeuroFrontiers
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
On the Frontlines of Schizophrenia
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Steven Paul, MD
- Steven Paul, MD
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiers
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Steven Paul, MD
- Steven Paul, MD

19/11